Needham & Company Maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Positive Outcome for Par as a Result of Teva-Cephalon Merger

Go back to Needham & Company Maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Positive Outcome for Par as a Result of Teva-Cephalon Merger
Cephalon, Inc. (NASDAQ: CEPH) Delayed: 81.49 --0 (-0%)
Previous Close $81.49    52 Week High $81.49 
Open $3.97    52 Week Low $54.15 
Day High $81.49    P/E 11.98 
Day Low $81.49    EPS $6.80 
Volume 1,914       

Par Pharmaceutical Cos., Inc. (NYSE: PRX) Delayed: 49.98 --0 (-0%)
Previous Close $49.98    52 Week High $52.33 
Open $0.02    52 Week Low $26.57 
Day High $49.98    P/E 24.26 
Day Low $49.98    EPS $2.06 
Volume 7,000       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 36.77 +0.25 (0.68%)
Previous Close $36.52    52 Week High $66.55 
Open $36.26    52 Week Low $37.82 
Day High $36.81    P/E N/A 
Day Low $36.09    EPS $0.00 
Volume 2,332,461